Search research articles
Contact Us
Filters
Showing results (41-50 of 99) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2016
First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction
Morie A Gertz, Heather Landau, Raymond L Comenzo, et al.
Blood Advances
|
February 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
Mark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, et al.
Leukemia & Lymphoma
|
January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation
Gunjan L Shah, Heather Landau, Dory Londono, et al.
Blood
|
March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Nikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
Leukemia & Lymphoma
|
May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance
Hani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
September 18, 2023
Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis
Morie Gertz, Rafat Abonour, Sarah N Gibbs, et al.
Leukemia & Lymphoma
|
June 1, 2022
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach
Oscar B Lahoud, Heather Landau, James Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CT
Eric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
Journal of Onco-Nephrology
|
February 18, 2026
Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United States
Samhita Boppana, Christopher D Blosser, Allison B Webber, et al.
JCO Precision Oncology
|
September 11, 2020
Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring <i>BRAF</i> <sup>V600</sup> Mutations: A Cohort of the Histology-Independent VE-BASKET Study
Noopur Raje, Ian Chau, David M Hyman, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 99) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2016
First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction
Morie A Gertz, Heather Landau, Raymond L Comenzo, et al.
Blood Advances
|
February 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
Mark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, et al.
Leukemia & Lymphoma
|
January 13, 2017
Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation
Gunjan L Shah, Heather Landau, Dory Londono, et al.
Blood
|
March 30, 2016
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
Nikoletta Lendvai, Andrew J Yee, Ioanna Tsakos, et al.
Leukemia & Lymphoma
|
May 10, 2017
Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance
Hani Hassoun, Mikhail Roshal, Joshua Sabari, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
September 18, 2023
Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis
Morie Gertz, Rafat Abonour, Sarah N Gibbs, et al.
Leukemia & Lymphoma
|
June 1, 2022
Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: a case for response-adapted approach
Oscar B Lahoud, Heather Landau, James Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CT
Eric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
Journal of Onco-Nephrology
|
February 18, 2026
Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United States
Samhita Boppana, Christopher D Blosser, Allison B Webber, et al.
JCO Precision Oncology
|
September 11, 2020
Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring <i>BRAF</i> <sup>V600</sup> Mutations: A Cohort of the Histology-Independent VE-BASKET Study
Noopur Raje, Ian Chau, David M Hyman, et al.
Page
of 10